BBCNEWS Click June 4, 2024 01:50:00
In these patients, we want to avoid as much as possible a heavy treatment that can be considered in itself as a new disease. so that's why you want to identify the patients that are not likely to relapse. 0kin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company's working on an updated version for those in the uk. what does an oncologist who's used to having difficult conversations with patients make of it, though? what we do now in terms of assessment of the risk is to have the standard i information, the standard clinical ...